These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12137851)

  • 1. Cytotoxicity of arsenic trioxide to transitional carcinoma cells.
    Pu YS; Hour TC; Chen J; Huang CY; Guan JY; Lu SH
    Urology; 2002 Aug; 60(2):346-50. PubMed ID: 12137851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide as a novel anticancer agent against human transitional carcinoma--characterizing its apoptotic pathway.
    Pu YS; Hour TC; Chen J; Huang CY; Guan JY; Lu SH
    Anticancer Drugs; 2002 Mar; 13(3):293-300. PubMed ID: 11984073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
    Maeda H; Hori S; Ohizumi H; Segawa T; Kakehi Y; Ogawa O; Kakizuka A
    Cell Death Differ; 2004 Jul; 11(7):737-46. PubMed ID: 15002036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells.
    Pu YS; Chen J; Huang CY; Guan JY; Lu SH; Hour TC
    J Urol; 2001 Jun; 165(6 Pt 1):2082-5. PubMed ID: 11371932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
    Wu XX; Ogawa O; Kakehi Y
    Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide.
    Hour TC; Huang CY; Lin CC; Chen J; Guan JY; Lee JM; Pu YS
    Anticancer Drugs; 2004 Sep; 15(8):779-85. PubMed ID: 15494640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines.
    Du YH; Ho PC
    Cancer Chemother Pharmacol; 2001 Jun; 47(6):481-90. PubMed ID: 11459200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines.
    Uslu R; Sanli UA; Sezgin C; Karabulut B; Terzioglu E; Omay SB; Goker E
    Clin Cancer Res; 2000 Dec; 6(12):4957-64. PubMed ID: 11156257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
    Huan SY; Yang CH; Chen YC
    Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation.
    Ong PS; Chan SY; Ho PC
    Int J Oncol; 2011 Jun; 38(6):1731-9. PubMed ID: 21455570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of arsenic trioxide (As2O3) combined with BSO on K562/ADM cell and its mechanisms].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):438-43. PubMed ID: 18072624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells.
    Miyajima A; Nakashima J; Yoshioka K; Tachibana M; Tazaki H; Murai M
    Br J Cancer; 1997; 76(2):206-10. PubMed ID: 9231920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide.
    Zhang TC; Cao EH; Li JF; Ma W; Qin JF
    Eur J Cancer; 1999 Aug; 35(8):1258-63. PubMed ID: 10615238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells.
    Yang CH; Kuo ML; Chen JC; Chen YC
    Br J Cancer; 1999 Nov; 81(5):796-9. PubMed ID: 10555748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine.
    Han YH; Kim SZ; Kim SH; Park WH
    Mol Cells; 2008 Aug; 26(2):158-64. PubMed ID: 18596414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the resveratrol and arsenic trioxide combination induced apoptosis and its mechanism on lung adenocarcinoma cells].
    Gu S; Chen C; Jiang X; Zhang Z
    Wei Sheng Yan Jiu; 2016 Jan; 45(1):87-92. PubMed ID: 26987203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level.
    Cheng B; Yang X; An L; Gao B; Liu X
    Auris Nasus Larynx; 2010 Feb; 37(1):89-94. PubMed ID: 19574005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins.
    Siegsmund MJ; Marx C; Seemann O; Schummer B; Steidler A; Toktomambetova L; Köhrmann KU; Rassweiler J; Alken P
    Urol Res; 1999 Jun; 27(3):157-63. PubMed ID: 10422815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
    J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.